View all IQVIA events


The CAR T-Cell therapy landscape shows strong and diverse infrastructures economically, as well as clinically. In this webinar, we explore real-world evidence generation beyond clinical trials, with a focus on economic challenges, outcomes measurements, especially how CAR T-cell data assets can be leveraged to equip life science companies for multi-stakeholder agreements in the future.